pyrimidine-4-carbaldehyde, 95.0%, 5g

3,7,11,15-Tetramethylhexadecan-1-ol>95.0%(GC)5g

Methyl 4-bromo-5-ethylthiophene-2-carboxylate, 95%, 5g

N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide, 98%, 50mg

Flacone per ibridazione rivestito in PVC, Altezza, 150 mm, 35 mm, 1 Pezzo

rel-(1r,4r)-4-((2-Phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexan-1-ol, 98%, 100mg

(R)-1-(2,4-Dichlorophenyl)ethanamine, 95.0%, 250mg

4-Bromo-3-hydroxybenzonitrile, 95.0%, 1g

7-(But-2-yn-1-yl)-8-ethoxy-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (Linagliptin Impurity), 97%, 50mg

3-(3-Fluorophenoxy)benzonitrile, 2.5g

5-(4-Methoxycarbonylphenyl)-10,15,20-triphenylporphyrin, 90%, 1g

3,5-dichloro-2'-thiomorpholinomethyl benzophenone, 97.0%, 1g

4-(Tert-butyl)-1-methylcyclohexane-1-carboxylic acid, 95%, 100mg